Transcranial Magnetic Stimulation (TMS) System
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The Department of the Army has awarded a Firm Fixed-Price contract to Neuromodulatory Devices & Applications, Inc. for a Transcranial Magnetic Stimulation (TMS) System for the Department of Mental Health at Dwight D. Eisenhower Army Medical Center (DDEAMC), Fort Gordon, GA. This non-competitive award, justified under FAR 12.102(b), ensures critical mental health treatment capabilities.
Scope of Work
The awarded contract provides a Transcranial Magnetic Stimulation (TMS) system, including all necessary components and a yearly subscription. This system will be utilized in the Residential Treatment Facility at DDEAMC to treat depression and other mental health and neurological conditions. Key requirements included fitting within limited space, aligning with current treatment practices, and not requiring new instrumentation.
Contract & Timeline
- Awardee: Neuromodulatory Devices & Applications, Inc.
- Contract Type: Firm Fixed-Price (FFP)
- Duration: Five years (base year plus four one-year options), from May 20, 2026, to May 19, 2031.
- Funding: FY26 DHP funds.
- Set-Aside: Not applicable (sole-source justification).
- Award Notice Published: April 28, 2026.
Evaluation & Justification
This award was made on a non-competitive basis, justified as "other than full and open competition" under FAR 12.102(b). Market research, including a Sources Sought and a Notice of Intent to sole source, identified Neuromodulatory Devices & Applications, Inc. as the only vendor capable of meeting the specific requirements. Effective competition was not anticipated.
Additional Notes
The justification highlights that failure to award this contract could jeopardize the mission of DDEAMC's Residential Treatment Facility and negatively impact patient care. The government will continue to monitor the market for potential future competition.